Elizabeth S Duke
7PUBLICATIONS
57CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jun 25, 2024
US Food and Drug Administration Approval Summary: Eflornithine for High-Risk Neuroblastoma After Prior Multiagent, Multimodality Therapy.Elizabeth S Duke, Diana Bradford, Arup K Sinha
|Feb 15, 2024
Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials: An FDA Educational Symposium.Jason Fangusaro, Robert A Avery, Michael J Fisher
|Jun 02, 2023
FDA Approval Summary: Selpercatinib for the Treatment of Advanced RET Fusion-Positive Solid Tumors.Elizabeth S Duke, Diana Bradford, Michelle Marcovitz
|Dec 02, 2022
Highlights of FDA Oncology Approvals in 2022: Tissue-Agnostic Indications, Dosage Optimization, and Diversity in Drug Development.Elizabeth S Duke, Michael J Fusco, Patrick DeMoss
|Sep 16, 2022
FDA Approval Summary: Mobocertinib for Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations.Elizabeth S Duke, Liza Stapleford, Nicole Drezner
Pageof 2
Frequent Collaborators
4 joint publications
Harpreet Singh
4 joint publications
Richard Pazdur
3 joint publications
Pallavi S Mishra-Kalyani
3 joint publications
Diana Bradford
2 joint publications
Abhilasha Nair
2 joint publications
Anup K Amatya
2 joint publications
Martha Donoghue
2 joint publications
Jeanne Fourie Zirkelbach
2 joint publications
Youwei Bi
2 joint publications
Barbara Scepura
